shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > Entertainment News > Hollywood News > Article > TXT debuts at number 4 on Billboard 200

TXT debuts at number 4 on Billboard 200

Updated on: 23 May,2022 04:35 PM IST  |  mumbai
mid-day online correspondent |

Minisode 2: Thursday’s Child becomes 6th TOMORROW X TOGETHER album to chart on the Billboard 200

TXT debuts at number 4 on Billboard 200

Photo Courtesy of BIGHIT MUSIC

TXT (TOMORROW X TOGETHER) reached a new career high at No.4 on the Billboard 200. According to an article by Billboard today, TOMORROW X TOGETHER (Soobin, Yeonjun, Beomgyu, Taehyun, Hueningkai) have charted their 4th EP, minisode 2: Thursday’s Child, at No.4 on the Billboard 200, as well as No.1 on Billboard’s Top Album Sales chart with the third-largest sales week of any album in 2022.


Minisode 2: Thursday’s Child marks TOMORROW X TOGETHER’s sixth entry into the Billboard 200 and second consecutive entry into the chart’s Top 5. The band’s debut album, The Dream Chapter: STAR, charted at No.140; the third EP, Minisode1 : Blue Hour, charted at No.25; the Japanese first studio album, Still Dreaming, charted at No.173; the second studio album, The Chaos Chapter: Freeze, charted at No.5; the Japanese first EP, Chaotic Wonderland, charted at No.177; and the newest 4th EP, minisode 2: Thursday’s Child, charted at No.4.


Gen Z’s ‘it’ boys will be meeting their fans worldwide through their upcoming first world tour, ‘TOMORROW X TOGETHER WORLD TOUR <ACT : LOVE SICK>.’


"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK